PUBLICATIONS OF THE PROBIO TEAM 

The ProBio trial: molecular biomarkers for advancing personalized treatment decision in patients with metastatic castration-resistant prostate cancer (See paper)

78.png

Androgen Receptor Burden and Poor Response to Abiraterone or Enzalutamide in TP53 Wild-Type Metastatic Castration-Resistant Prostate Cancer (See paper)

78.png

Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesis (See paper)

28.png

TP53 Outperforms Other Androgen Receptor Biomarkers to Predict Abiraterone or Enzalutamide Outcome in Metastatic Castration-Resistant Prostate Cancer (See paper)

20.png

Comprehensive Profiling of the Androgen Receptor in Liquid Biopsies from Castration-Resistant Prostate Cancer Reveals Novel Intra-AR Structural Variation and Splice Variant Expression Patterns (See paper)

18.png

The In Vitro Stability of Circulating Tumour DNA (See paper)

1_index.png